↓ Skip to main content

Perception of Availability, Accessibility, and Affordability of COVID-19 Vaccines and Hesitancy: A Cross-Sectional Study in India

Overview of attention for article published in Vaccines, November 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Perception of Availability, Accessibility, and Affordability of COVID-19 Vaccines and Hesitancy: A Cross-Sectional Study in India
Published in
Vaccines, November 2022
DOI 10.3390/vaccines10122009
Pubmed ID
Authors

Akshay Ayappan, Bijaya Kumar Padhi, Ananthesh L, Raushan Kumar Chaudhary, Uday Venkat Mateti, Adithi Kellarai, Mazhuvanchery Kesavan Unnikrishnan, Jaclyn Drishal Dsouza, Ali Davod Parsa, Russell Kabir, Ranjit Sah

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 19%
Student > Bachelor 2 8%
Student > Master 2 8%
Student > Postgraduate 2 8%
Professor 1 4%
Other 0 0%
Unknown 14 54%
Readers by discipline Count As %
Unspecified 5 19%
Nursing and Health Professions 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Medicine and Dentistry 1 4%
Other 0 0%
Unknown 16 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2022.
All research outputs
#17,350,824
of 25,460,285 outputs
Outputs from Vaccines
#2,670
of 4,307 outputs
Outputs of similar age
#278,819
of 488,334 outputs
Outputs of similar age from Vaccines
#201
of 338 outputs
Altmetric has tracked 25,460,285 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.3. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 488,334 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 338 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.